Product image of Medisinsk Lystgass (Nitrous Oxide) supplied by GNH India

Medisinsk Lystgass

Active Ingredient:
Nitrous Oxide
Origin:
EU

Medisinsk Lystgass (Nitrous Oxide)

Nitrous oxide, the active ingredient in Medisinsk Lystgass, is a inhalational anesthetic presented as a medical gas for inhalation use. It provides analgesia and sedation for minor procedures, procedural sedation and as an adjunct to general anesthesia in patients of all ages.
GNH India supplies Medisinsk Lystgass as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Air Liquide Sante International

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Nitrous oxide is an inhalational anesthetic used for analgesia and sedation in various clinical settings.
  • Minor procedural analgesia: provides pain relief during dental, obstetric or minor surgical procedures.
  • Procedural sedation: induces moderate sedation for diagnostic or therapeutic interventions.
  • Adjunct to general anesthesia: enhances anesthetic depth and reduces the requirement for other agents during surgery.

How It Works

  • Inhaled nitrous oxide produces analgesia and sedation primarily by antagonizing N‑methyl‑D‑aspartate (NMDA) receptors, which reduces excitatory neurotransmission, and by facilitating the release of endogenous opioids that activate µ‑opioid pathways. These actions together diminish pain perception and produce a calming effect without complete loss of consciousness.

Side Effects

Nitrous oxide may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Nausea: occasional feeling of queasiness during or after inhalation.
  • Vomiting: may occur in sensitive individuals.
  • Dizziness: light‑headed sensation during administration.
  • Headache: mild to moderate headache after exposure.
  • Euphoria: brief feeling of well‑being.
  • Increased heart rate: mild tachycardia during use.

Serious or Rare Side Effects

  • Respiratory depression: reduced breathing effort requiring monitoring.
  • Severe hypotension: marked drop in blood pressure.
  • Loss of consciousness: rare but possible with high concentrations.
  • Vitamin B12 deficiency: prolonged occupational exposure may impair B12 metabolism.
  • Peripheral neuropathy: rare neurological complication with chronic exposure.

Precautions & Warnings

  • Nitrous oxide should be administered with careful clinical assessment and appropriate monitoring.
  • Assess airway: confirm patency and adequate ventilation before inhalation.
  • Monitor oxygenation: ensure supplemental oxygen is provided to prevent hypoxia.
  • Contraindications: avoid use in patients with pneumothorax, severe COPD, or recent middle‑ear surgery.
  • Pregnancy caution: use only if benefits outweigh potential risks, as safety data are limited.
  • Equipment check: verify cylinder integrity and regulator function prior to use.
  • Store at ambient temperature: keep cylinder in original container, protect from heat and direct sunlight.

Avoid Interactions

Nitrous oxide can interact with other central nervous system depressants and certain anesthetic agents.

Major Interactions (Avoid)

  • Volatile anesthetics: combined use may cause excessive sedation.
  • Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.
  • High‑dose opioids: may potentiate respiratory depression.

Moderate Interactions (Monitor Closely)

  • Benzodiazepines: increased sedative effect, monitor level of consciousness.
  • Alcohol: additive CNS depression, advise patient to abstain.
  • Sedating antihistamines: may enhance drowsiness, observe patient response.

Frequently Asked Questions

Medisinsk Lystgass is a medical‑grade nitrous oxide gas used to provide analgesia during minor procedures, to produce moderate sedation for diagnostic or therapeutic interventions, and as an adjunct to general anesthesia to reduce the amount of other anesthetic agents required.

Nitrous oxide works by blocking NMDA receptors, which reduces excitatory neurotransmission, and by stimulating the release of endogenous opioids that activate µ‑opioid receptors. This dual action diminishes pain perception and produces a calming, sedative effect without causing full unconsciousness.

The specific concentration and duration of nitrous oxide administration are determined by the prescribing clinician based on the procedure, patient age, weight, and clinical condition. Dosing is individualized and should follow local anesthesia guidelines and institutional protocols.

Safety data for nitrous oxide in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant, and only under close medical supervision.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Nitrous oxide has a rapid onset and quick recovery profile compared with volatile agents such as sevoflurane or desflurane. It provides moderate analgesia and sedation but is less potent, making it suitable for minor procedures and as an adjunct, whereas other inhalational anesthetics are often used for full general anesthesia.

Store the nitrous oxide cylinder at ambient temperature, away from direct sunlight and heat sources. Keep it in the original packaging, secure the valve, and ensure the cylinder is upright to prevent regulator damage. Follow local regulations for compressed gas storage.

The gas is delivered through a calibrated regulator and breathing circuit, mixed with oxygen as required. Administration is performed by trained personnel who monitor the patient’s respiratory status, oxygen saturation and level of sedation throughout the procedure.

Serious risks include respiratory depression, severe hypotension, loss of consciousness, and, with prolonged exposure, vitamin B12 deficiency leading to neuropathy. Immediate monitoring and supplemental oxygen are essential to mitigate these hazards.

Patients with untreated pneumothorax, severe chronic obstructive pulmonary disease, recent middle‑ear surgery, or known hypersensitivity to nitrous oxide should avoid its use. Additionally, individuals taking MAO inhibitors or high‑dose opioids should be evaluated carefully before administration.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.